CorMedix reports Q3 pro forma revenue exceeding $125M; hikes FY revenue guidance

CorMedix (NASDAQ:CRMD) has announced strong preliminary unaudited third-quarter financial results and a significant update to ...

CorMedix Share Surge on Boosted FY Outlook

Shares of CorMedix surged after the company upped its full-year revenue outlook. The stock rose 13% to $11.54 in premarket trading after closing last Friday up 26% this year.

Jeffries warns of ‘swift and decisive legal action’ if Republicans refuse to seat Grijalva

House Minority Leader Hakeem Jeffries (D-N.Y.) said Friday that Democrats will respond with quick legal action if Speaker ...
CRN

HPE Clarifies Post-Juniper Networks Acquisition ‘Revenue Growth Outlook’ In Wake Of 9 Percent Share Drop

Here’s a look at why HPE is clarifying its revenue growth outlook in the wake of a 9 percent drop in shares after issuing its ...

Johnson refuses to swear in Grijalva, brushes aside Democrats' legal threat — for now

Democrats have threatened legal action if Rep.-elect Adelita Grijalva isn't sworn in Friday after winning her special ...

Jeffries presses Speaker Johnson to seat newly elected Grijalva

House Minority Leader Hakeem Jeffries (D-N.Y.) is pressing Speaker Mike Johnson (R-La.) to seat a newly elected Democrat who ...
Asianet Newsable on MSN

CRMD Stock Is The Talk Of The Town Today: What’s The Latest 2025 Revenue Forecast?

CorMedix said it was raising its fiscal 2025 pro forma net revenue guidance to at least $375 million. The company said the ...